Open access
Open access
Powered by Google Translator Translator

Pediatrics (all articles)

AAP Policy Statement | Crowding in the emergency department: challenges and recommendations for the care of children

28 Feb, 2023 | 13:50h | UTC

Guideline: Crowding in the Emergency Department: Challenges and Recommendations for the Care of Children – Pediatrics

Technical Report: Crowding in the Emergency Department: Challenges and Best Practices for the Care of Children – Pediatrics

News Release: Crowding in the ED: AAP guidance offers solutions to complex problem – American Academy of Pediatrics

 


SR | Insufficient evidence to recommend Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia

28 Feb, 2023 | 13:39h | UTC

Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia – Cochrane Library

 


The adult and pediatric palliative care: differences and shared issues

28 Feb, 2023 | 13:30h | UTC

The adult and pediatric palliative care: differences and shared issues – Journal of Anesthesia, Analgesia and Critical Care

 


Cross-sectional study | Risk factors for hearing loss at birth in newborns with congenital CMV infection

28 Feb, 2023 | 13:20h | UTC

Risk Factors for Hearing Loss at Birth in Newborns With Congenital Cytomegalovirus Infection – JAMA Pediatrics (link to abstract – $ for full-text)

Commentary: Factors ID’d for Hearing Loss in Newborns With Congenital Cytomegalovirus – HealthDay

 

Commentaries on Twitter

 


RCT | Tight glycemic control did not preserve pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes

27 Feb, 2023 | 13:16h | UTC

Summary: The study aimed to determine if intensive diabetes management with an automated insulin delivery system could help preserve pancreatic beta cell function in youth with newly diagnosed type 1 diabetes. The randomized clinical trial included 113 youths aged 7 to 17 years and found that although the mean time in the target range of 70 to 180 mg/dL was 78% in the intensive management group vs. 64% in the standard care group, intensive diabetes management did not affect the decline in pancreatic C-peptide secretion at 52 weeks. The study concluded that near normalization of glucose levels instituted immediately after diagnosis of type 1 diabetes did not preserve pancreatic beta cell function in youth.

Article: Effect of Tight Glycemic Control on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes – JAMA (free for a limited period)

 

Commentary on Twitter

 


RCT | Verapamil partially preserved pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes

27 Feb, 2023 | 13:14h | UTC

Summary: The study aimed to determine whether verapamil could preserve pancreatic beta cell function in children and adolescents with newly diagnosed type 1 diabetes. The randomized clinical trial involved 88 participants who were given either verapamil or placebo once daily for 52 weeks. The study found that C-peptide levels were 30% higher in the verapamil group compared to the placebo group at 52 weeks, and the percentage of participants with a 52-week peak C-peptide level of 0.2 pmol/mL or greater was 95% in the verapamil group compared to 71% in the placebo group. The study also found that verapamil was well tolerated with few adverse events. The results suggest that verapamil may partially preserve stimulated C-peptide secretion in children and adolescents with newly diagnosed type 1 diabetes. However, further studies with patient-relevant outcomes are needed to determine the long-term effectiveness and the optimal length of therapy.

Article: Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial – JAMA (free for a limited period)

Editorial: Preserving Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes – JAMA (free for a limited period)

News Release: Verapamil shows beneficial effect on the pancreas in children with newly-diagnosed type 1 diabetes – University of Minnesota

 

Commentary on Twitter

 


Review | Diagnostic workup of childhood interstitial lung disease

27 Feb, 2023 | 12:50h | UTC

Diagnostic workup of childhood interstitial lung disease – European Respiratory Review

 

Commentary on Twitter

 


Review | Management of gastrointestinal foreign bodies with brief review of the guidelines

24 Feb, 2023 | 13:36h | UTC

Management of Gastrointestinal Foreign Bodies with Brief Review of the Guidelines – Pediatric Gastroenterology, Hepatology & Nutrition

 


SR | The impact of Antimicrobial Stewardship Programs in pediatric emergency departments and primary care

24 Feb, 2023 | 13:20h | UTC

The impact of Antimicrobial Stewardship Programmes in paediatric emergency departments and primary care: a systematic review – Therapeutic Advances in Infectious Disease

 


M-A | Low-dose insulin infusion is safe and effective in treating diabetic ketoacidosis in children

23 Feb, 2023 | 13:40h | UTC

Summary: The article discusses a systematic review and meta-analysis of randomized controlled trials comparing low-dose insulin at 0.05 units/kg/hr to standard dose at 0.1 units/kg/hr for children with diabetic ketoacidosis (DKA). The study found that low-dose insulin infusion is probably as efficacious and safer than standard-dose insulin in treating DKA in children, as it has no effect on the time to resolution of hyperglycemia or acidosis and probably reduces the risk of developing hypokalemia and hypoglycemia. However, the results are limited by imprecision and generalizability to other settings since all studies were performed in a single country. Therefore, further studies are required to identify the optimal insulin dose for children with DKA in terms of safety and effectiveness.

Article: Insulin Infusion Dosing in Pediatric Diabetic Ketoacidosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Critical Care Explorations

 


M-A | Disordered eating affects 1 in 5 children and adolescents

23 Feb, 2023 | 13:33h | UTC

Summary: The text reports the findings of a systematic review and meta-analysis that included 32 studies on the global proportion of disordered eating in children and adolescents aged 6 to 18 years, assessed with the SCOFF questionnaire, a widely used screening measure for eating disorders. The review found that approximately 22% of children and adolescents showed disordered eating, which was higher among girls, older adolescents, and those with higher body mass index. The high figures are concerning from a public health perspective and highlight the need for prevention strategies to address disordered eating. The study has limitations, including the cross-sectional nature of most of the included studies and the use of self-report questionnaires to assess disordered eating, which may be subject to bias.

Article: Global Proportion of Disordered Eating in Children and Adolescents: A Systematic Review and Meta-analysis – JAMA Pediatrics (free for a limited period)

Commentary: What is disordered eating? And why do 20% of the world’s kids show signs of it? Experts explain – CNN

 


SR | Glucocorticoids for croup in children

23 Feb, 2023 | 13:17h | UTC

Glucocorticoids for croup in children – Cochrane Library

 


Review | Constipation in children and adolescents

23 Feb, 2023 | 13:06h | UTC

Constipation in Children and Adolescents – Deutsches Ärzteblatt international

 


M-A | Interventions for myopia control in children

22 Feb, 2023 | 12:36h | UTC

Interventions for myopia control in children: a living systematic review and network meta‐analysis – Cochrane Library

Related:

RCT | Effect of low-concentration atropine eyedrops vs. placebo on myopia incidence in children

Crossover RCT | Spectacle lenses with highly aspherical lenslets for slowing myopia.

RCT | Effect of text messaging parents of school-aged children on outdoor time to control myopia.

RCT | Myopia control effect of repeated low-level red-light therapy in children.

RCT: Spectacle lenses with aspherical lenslets for myopia control vs. single-vision spectacle lenses.

Randomized trial: Effect of High add power, medium add power, or single-vision contact lenses on myopia progression in children

 


Health and nutrition claims for infant formula: international cross sectional survey

22 Feb, 2023 | 12:31h | UTC

Health and nutrition claims for infant formula: international cross sectional survey – The BMJ

Editorial: Poorly substantiated health claims on infant formula – The BMJ

News Release: Most health claims on infant formula products seem to have little evidence – BMJ Newsroom

Commentary: Little evidence to support health claims made on formula milk – BBC

 

Commentary from one of the authors on Twitter (thread – click for more)

https://twitter.com/mbrockwa/status/1626034305393893376

 


M-A | Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children

22 Feb, 2023 | 12:24h | UTC

Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis – JAMA Network Open

Commentary: Study Finds 3 Monoclonal Antibodies Reduce RSV Infections in High-Risk Infants, Children – HCP Live

 

Commentary on Twitter

 


SR | Probiotics for management of functional abdominal pain disorders in children

22 Feb, 2023 | 12:20h | UTC

Probiotics for management of functional abdominal pain disorders in children – Cochrane Library

 


Instant noodle burns common in pediatric scald injuries: Study highlights need for prevention efforts

21 Feb, 2023 | 11:50h | UTC

Summary: The study examined pediatric scald burns at the University of Chicago Burn Center between 2010 and 2020 and found that 31% of burns were attributed to instant noodles. Children with instant noodle burns were typically older, more likely to be Black/African American, and from lower socio-economic backgrounds. They were also more likely to be unsupervised at the time of the injury. While instant noodle burns were smaller and required less operative intervention than other scald burns, some still required hospitalization and were associated with complications. The study highlights the need for targeted burn prevention efforts to reduce the incidence of these common but serious injuries.

Article: Pediatric instant noodle burns: A ten-year single center retrospective study – Burns (link to abstract – $ for full-text)

Commentary: Why Instant Noodles Are a Danger to Your Kids – HealthDay

 


AHA Scientific Statement | Anesthetic care of the pregnant patient with cardiovascular disease

20 Feb, 2023 | 12:29h | UTC

Summary: The AHA emphasizes the need for specialized cardio-obstetric anesthesiology care for pregnant patients with cardiovascular disease, involving a multidisciplinary team of obstetricians, cardiologists, anesthesiologists, and other specialists as needed. The approach includes preoperative evaluation, intraoperative management, and postoperative care to maintain maternal hemodynamic stability, optimize oxygen delivery to the fetus, and avoid factors that exacerbate cardiovascular disease. Vaginal delivery with effective neuraxial analgesia is the preferred mode of delivery, with cesarean delivery used for obstetrical indications or high-risk patients. Specific recommendations are also provided for the management of patients with different types of cardiovascular disease, including congenital heart disease, valvular heart disease, pulmonary hypertension, and hypertrophic cardiomyopathy.

Article: Anesthetic Care of the Pregnant Patient With Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation

Top Things to Know: Statement on the anesthetic care of the pregnant patient with cardiovascular disease – American Heart Association

 


RCT | Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age

17 Feb, 2023 | 13:27h | UTC

Summary: The study was a combined phase 2-3 clinical trial that aimed to determine whether the BNT162b2 vaccine was safe, could elicit an immune response and was effective in preventing COVID-19 in healthy children. The trial was conducted on children aged 6 months to 11 years, with the findings presented for the 6 months to 4 years age group. The results indicated that the vaccine was safe, immunogenic, and effective in reducing the risk of symptomatic COVID-19 by 73.2% in children aged 6 months to 4 years. The vaccine was well-tolerated, and the side effects were mainly mild to moderate. The incidence of fever was similar among those who received the vaccine or a placebo.*

Article: Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age – New England Journal of Medicine (link to abstract – $ for full-text)

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


Consensus Paper | Pediatric traumatic hemorrhagic shock

17 Feb, 2023 | 13:15h | UTC

Pediatric traumatic hemorrhagic shock consensus conference recommendations – Journal of Trauma and Acute Care Surgery

Preface: Pediatric traumatic hemorrhagic shock consensus conference

Other articles in the supplement:

Pediatric traumatic hemorrhagic shock consensus conference research priorities

Building an optimal pediatric trauma program

Time is tissue: Barriers to timely transfusion after pediatric injury

Resuscitative practices and the use of low-titer group O whole blood in pediatric trauma

Tranexamic acid in pediatric hemorrhagic trauma

Blood banking considerations in pediatric trauma

Detecting traumatic brain injury–induced coagulopathy: What we are testing and what we are not

 


Retrospective Cohort | Lifetime risk of comorbidity in patients with simple congenital heart disease

17 Feb, 2023 | 12:57h | UTC

Lifetime risk of comorbidity in patients with simple congenital heart disease: a Danish nationwide study – European Heart Journal

Editorial: Addressing comorbidities in simple congenital heart disease: a critical step to achieve optimal long-term outcomes – European Heart Journal

 

Commentary on Twitter

 


10-year follow-up on preterm prelabor rupture of membranes: induced labor vs. expectant management childhood outcomes

16 Feb, 2023 | 15:05h | UTC

Summary: This study aimed to compare the long-term outcomes of children born after singleton pregnancies complicated by preterm prelabor rupture of membranes and managed by induction of labor vs. expectant management in RCTs undergone between 2007 and 2011. The study assessed the children’s cognition, motor function, and behavior as the primary outcomes. It found that expectant management did not improve long-term outcomes compared to induction of labor for children born after pregnancies with preterm prelabor (between 34 0/7 and 36 6/7 weeks of pregnancy) rupture of membranes. The confidence in the results of this follow-up study is diminished because only 35% of the children who participated in the original trials participated in the follow-up study.

Article: Childhood outcomes after induction of labor or expectant management for preterm prelabor rupture of membranes: a 10-year follow-up of the PPROMEXIL trials – American Journal of Obstetrics & Gynecology

 

*Note: This summary was created through the collaboration of a medical editor and ChatGPT.

 


Pediatric edible cannabis exposures and acute toxicity in the US: 2017–2021

16 Feb, 2023 | 15:00h | UTC

Pediatric Edible Cannabis Exposures and Acute Toxicity: 2017–2021 – Pediatrics

Commentaries:

The Number of American Kids Eating Cannabis Has Surged Dramatically – Science Alert

2017 to 2021 Saw Increase in Pediatric Edible Cannabis Exposure – HealthDay

 


SR | The impact of interventions to prevent neonatal healthcare-associated infections in low- and middle-income countries

16 Feb, 2023 | 14:47h | UTC

The Impact of Interventions to Prevent Neonatal Healthcare-associated Infections in Low- and Middle-income Countries: A Systematic Review – The Pediatric Infectious Disease Journal

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.